Skip to main content
PMC home page
The Journal of General Physiology logoLink to The Journal of General Physiology
. 1990 Jan 1;95(1):1–27. doi: 10.1085/jgp.95.1.1

Internal and external effects of dihydropyridines in the calcium channel of skeletal muscle

PMCID: PMC2216293  PMID: 2153750

Abstract

The agonist effect of the dihydropyridine (DHP) (-)Bay K 8644 and the inhibitory effects of nine antagonist DHPs were studied at a constant membrane potential of 0 mV in Ca channels of skeletal muscle transverse tubules incorporated into planar lipid bilayers. Four phenylalkylamines (verapamil, D600, D575, and D890) and d-cis-diltiazem were also tested. In Ca channels activated by 1 microM Bay K 8644, the antagonists nifedipine, nitrendipine, PN200-110, nimodipine, and pure enantiomer antagonists (+)nimodipine, (-)nimodipine, (+)Bay K 8644, inhibited activity in the concentration range of 10 nM to 10 microM. Effective doses (ED50) were 2 to 10 times higher when HDPs were added to the internal side than when added to the external side. This sidedness arises from different structure-activity relationships for DHPs on both sides of the Ca channel since the ranking potency of DHPs is PN200-110 greater than (-)nimodipine greater than nifedipine approximately S207- 180 on the external side while PN200-110 greater than S207-180 greater than nifedipine approximately (-)nimodipine on the internal side. A comparison of ED50's for inhibition of single channels by DHPs added to the external side and ED50's for displacement of [3H]PN200-110 bound to the DHP receptor, revealed a good quantitative agreement. However, internal ED50's of channels were consistently higher than radioligand binding affinities by up to two orders of magnitude. Evidently, Ca channels of skeletal muscle are functionally coupled to two DHP receptor sites on opposite sides of the membrane.

Full Text

The Full Text of this article is available as a PDF (1.5 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Affolter H., Coronado R. Agonists Bay-K8644 and CGP-28392 open calcium channels reconstituted from skeletal muscle transverse tubules. Biophys J. 1985 Aug;48(2):341–347. doi: 10.1016/S0006-3495(85)83789-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Affolter H., Coronado R. Sidedness of reconstituted calcium channels from muscle transverse tubules as determined by D600 and D890 blockade. Biophys J. 1986 Mar;49(3):767–771. doi: 10.1016/S0006-3495(86)83703-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bean B. P. Nitrendipine block of cardiac calcium channels: high-affinity binding to the inactivated state. Proc Natl Acad Sci U S A. 1984 Oct;81(20):6388–6392. doi: 10.1073/pnas.81.20.6388. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bolger G. T., Gengo P., Klockowski R., Luchowski E., Siegel H., Janis R. A., Triggle A. M., Triggle D. J. Characterization of binding of the Ca++ channel antagonist, [3H]nitrendipine, to guinea-pig ileal smooth muscle. J Pharmacol Exp Ther. 1983 May;225(2):291–309. [PubMed] [Google Scholar]
  5. Borsotto M., Norman R. I., Fosset M., Lazdunski M. Solubilization of the nitrendipine receptor from skeletal muscle transverse tubule membranes. Interactions with specific inhibitors of the voltage-dependent Ca2+ channel. Eur J Biochem. 1984 Aug 1;142(3):449–455. doi: 10.1111/j.1432-1033.1984.tb08307.x. [DOI] [PubMed] [Google Scholar]
  6. Callewaert G., Hanbauer I., Morad M. Modulation of calcium channels in cardiac and neuronal cells by an endogenous peptide. Science. 1989 Feb 3;243(4891):663–666. doi: 10.1126/science.2536955. [DOI] [PubMed] [Google Scholar]
  7. Campbell K. P., Leung A. T., Sharp A. H. The biochemistry and molecular biology of the dihydropyridine-sensitive calcium channel. Trends Neurosci. 1988 Oct;11(10):425–430. doi: 10.1016/0166-2236(88)90193-2. [DOI] [PubMed] [Google Scholar]
  8. Catterall W. A., Seagar M. J., Takahashi M. Molecular properties of dihydropyridine-sensitive calcium channels in skeletal muscle. J Biol Chem. 1988 Mar 15;263(8):3535–3538. [PubMed] [Google Scholar]
  9. Cheng Y., Prusoff W. H. Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol. 1973 Dec 1;22(23):3099–3108. doi: 10.1016/0006-2952(73)90196-2. [DOI] [PubMed] [Google Scholar]
  10. Coronado R., Affolter H. Insulation of the conduction pathway of muscle transverse tubule calcium channels from the surface charge of bilayer phospholipid. J Gen Physiol. 1986 Jun;87(6):933–953. doi: 10.1085/jgp.87.6.933. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Coronado R., Smith J. S. Monovalent ion current through single calcium channels of skeletal muscle transverse tubules. Biophys J. 1987 Mar;51(3):497–502. doi: 10.1016/S0006-3495(87)83371-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Curtis B. M., Catterall W. A. Reconstitution of the voltage-sensitive calcium channel purified from skeletal muscle transverse tubules. Biochemistry. 1986 Jun 3;25(11):3077–3083. doi: 10.1021/bi00359a002. [DOI] [PubMed] [Google Scholar]
  13. Ehrlich B. E., Schen C. R., Garcia M. L., Kaczorowski G. J. Incorporation of calcium channels from cardiac sarcolemmal membrane vesicles into planar lipid bilayers. Proc Natl Acad Sci U S A. 1986 Jan;83(1):193–197. doi: 10.1073/pnas.83.1.193. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Ellis S. B., Williams M. E., Ways N. R., Brenner R., Sharp A. H., Leung A. T., Campbell K. P., McKenna E., Koch W. J., Hui A. Sequence and expression of mRNAs encoding the alpha 1 and alpha 2 subunits of a DHP-sensitive calcium channel. Science. 1988 Sep 23;241(4873):1661–1664. doi: 10.1126/science.2458626. [DOI] [PubMed] [Google Scholar]
  15. Flockerzi V., Oeken H. J., Hofmann F., Pelzer D., Cavalié A., Trautwein W. Purified dihydropyridine-binding site from skeletal muscle t-tubules is a functional calcium channel. Nature. 1986 Sep 4;323(6083):66–68. doi: 10.1038/323066a0. [DOI] [PubMed] [Google Scholar]
  16. Fosset M., Jaimovich E., Delpont E., Lazdunski M. [3H]nitrendipine receptors in skeletal muscle. J Biol Chem. 1983 May 25;258(10):6086–6092. [PubMed] [Google Scholar]
  17. Galizzi J. P., Borsotto M., Barhanin J., Fosset M., Lazdunski M. Characterization and photoaffinity labeling of receptor sites for the Ca2+ channel inhibitors d-cis-diltiazem, (+/-)-bepridil, desmethoxyverapamil, and (+)-PN 200-110 in skeletal muscle transverse tubule membranes. J Biol Chem. 1986 Jan 25;261(3):1393–1397. [PubMed] [Google Scholar]
  18. Galizzi J. P., Fosset M., Lazdunski M. Properties of receptors for the Ca2+-channel blocker verapamil in transverse-tubule membranes of skeletal muscle. Stereospecificity, effect of Ca2+ and other inorganic cations, evidence for two categories of sites and effect of nucleoside triphosphates. Eur J Biochem. 1984 Oct 15;144(2):211–215. doi: 10.1111/j.1432-1033.1984.tb08451.x. [DOI] [PubMed] [Google Scholar]
  19. Garcia M. L., Trumble M. J., Reuben J. P., Kaczorowski G. J. Characterization of verapamil binding sites in cardiac membrane vesicles. J Biol Chem. 1984 Dec 25;259(24):15013–15016. [PubMed] [Google Scholar]
  20. Green F. J., Farmer B. B., Wiseman G. L., Jose M. J., Watanabe A. M. Effect of membrane depolarization on binding of [3H]nitrendipine to rat cardiac myocytes. Circ Res. 1985 Apr;56(4):576–585. doi: 10.1161/01.res.56.4.576. [DOI] [PubMed] [Google Scholar]
  21. Hamilton S. L., Yatani A., Brush K., Schwartz A., Brown A. M. A comparison between the binding and electrophysiological effects of dihydropyridines on cardiac membranes. Mol Pharmacol. 1987 Mar;31(3):221–231. [PubMed] [Google Scholar]
  22. Hescheler J., Pelzer D., Trube G., Trautwein W. Does the organic calcium channel blocker D600 act from inside or outside on the cardiac cell membrane? Pflugers Arch. 1982 Jun;393(4):287–291. doi: 10.1007/BF00581411. [DOI] [PubMed] [Google Scholar]
  23. Hess P., Lansman J. B., Tsien R. W. Different modes of Ca channel gating behaviour favoured by dihydropyridine Ca agonists and antagonists. Nature. 1984 Oct 11;311(5986):538–544. doi: 10.1038/311538a0. [DOI] [PubMed] [Google Scholar]
  24. Horne W. A., Abdel-Ghany M., Racker E., Weiland G. A., Oswald R. E., Cerione R. A. Functional reconstitution of skeletal muscle Ca2+ channels: separation of regulatory and channel components. Proc Natl Acad Sci U S A. 1988 Jun;85(11):3718–3722. doi: 10.1073/pnas.85.11.3718. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Hosey M. M., Lazdunski M. Calcium channels: molecular pharmacology, structure and regulation. J Membr Biol. 1988 Sep;104(2):81–105. doi: 10.1007/BF01870922. [DOI] [PubMed] [Google Scholar]
  26. Janis R. A., Rampe D., Sarmiento J. G., Triggle D. J. Specific binding of a calcium channel activator, [3H]BAY k 8644, to membranes from cardiac muscle and brain. Biochem Biophys Res Commun. 1984 May 31;121(1):317–323. doi: 10.1016/0006-291x(84)90725-3. [DOI] [PubMed] [Google Scholar]
  27. Janis R. A., Sarmiento J. G., Maurer S. C., Bolger G. T., Triggle D. J. Characteristics of the binding of [3H]nitrendipine to rabbit ventricular membranes: modification by other Ca++ channel antagonists and by the Ca++ channel agonist Bay K 8644. J Pharmacol Exp Ther. 1984 Oct;231(1):8–15. [PubMed] [Google Scholar]
  28. Kokubun S., Prod'hom B., Becker C., Porzig H., Reuter H. Studies on Ca channels in intact cardiac cells: voltage-dependent effects and cooperative interactions of dihydropyridine enantiomers. Mol Pharmacol. 1986 Dec;30(6):571–584. [PubMed] [Google Scholar]
  29. Lacerda A. E., Brown A. M. Nonmodal gating of cardiac calcium channels as revealed by dihydropyridines. J Gen Physiol. 1989 Jun;93(6):1243–1273. doi: 10.1085/jgp.93.6.1243. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Lee K. S., Tsien R. W. Mechanism of calcium channel blockade by verapamil, D600, diltiazem and nitrendipine in single dialysed heart cells. Nature. 1983 Apr 28;302(5911):790–794. doi: 10.1038/302790a0. [DOI] [PubMed] [Google Scholar]
  31. Leung A. T., Imagawa T., Block B., Franzini-Armstrong C., Campbell K. P. Biochemical and ultrastructural characterization of the 1,4-dihydropyridine receptor from rabbit skeletal muscle. Evidence for a 52,000 Da subunit. J Biol Chem. 1988 Jan 15;263(2):994–1001. [PubMed] [Google Scholar]
  32. Ma J., Coronado R. Heterogeneity of conductance states in calcium channels of skeletal muscle. Biophys J. 1988 Mar;53(3):387–395. doi: 10.1016/S0006-3495(88)83115-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Maan A. C., Hosey M. M. Analysis of the properties of binding of calcium-channel activators and inhibitors to dihydropyridine receptors in chick heart membranes. Circ Res. 1987 Sep;61(3):379–388. doi: 10.1161/01.res.61.3.379. [DOI] [PubMed] [Google Scholar]
  34. Meissner G. Adenine nucleotide stimulation of Ca2+-induced Ca2+ release in sarcoplasmic reticulum. J Biol Chem. 1984 Feb 25;259(4):2365–2374. [PubMed] [Google Scholar]
  35. Palade P. T., Almers W. Slow calcium and potassium currents in frog skeletal muscle: their relationship and pharmacologic properties. Pflugers Arch. 1985 Sep;405(2):91–101. doi: 10.1007/BF00584528. [DOI] [PubMed] [Google Scholar]
  36. Rampe D., Poder T., Zhao Z. Y., Schilling W. P. Calcium channel agonist and antagonist binding in a highly enriched sarcolemma preparation obtained from canine ventricle. J Cardiovasc Pharmacol. 1989 Apr;13(4):547–556. [PubMed] [Google Scholar]
  37. Rhodes D. G., Sarmiento J. G., Herbette L. G. Kinetics of binding of membrane-active drugs to receptor sites. Diffusion-limited rates for a membrane bilayer approach of 1,4-dihydropyridine calcium channel antagonists to their active site. Mol Pharmacol. 1985 Jun;27(6):612–623. [PubMed] [Google Scholar]
  38. Rosenberg R. L., Hess P., Reeves J. P., Smilowitz H., Tsien R. W. Calcium channels in planar lipid bilayers: insights into mechanisms of ion permeation and gating. Science. 1986 Mar 28;231(4745):1564–1566. doi: 10.1126/science.2420007. [DOI] [PubMed] [Google Scholar]
  39. Sanguinetti M. C., Kass R. S. Voltage-dependent block of calcium channel current in the calf cardiac Purkinje fiber by dihydropyridine calcium channel antagonists. Circ Res. 1984 Sep;55(3):336–348. doi: 10.1161/01.res.55.3.336. [DOI] [PubMed] [Google Scholar]
  40. Sarmiento J. G., Janis R. A., Katz A. M., Triggle D. J. Comparison of high affinity binding of calcium channel blocking drugs to vascular smooth muscle and cardiac sarcolemmal membranes. Biochem Pharmacol. 1984 Oct 15;33(20):3119–3123. doi: 10.1016/0006-2952(84)90066-2. [DOI] [PubMed] [Google Scholar]
  41. Scherer N. M., Toro M. J., Entman M. L., Birnbaumer L. G-protein distribution in canine cardiac sarcoplasmic reticulum and sarcolemma: comparison to rabbit skeletal muscle membranes and to brain and erythrocyte G-proteins. Arch Biochem Biophys. 1987 Dec;259(2):431–440. doi: 10.1016/0003-9861(87)90509-1. [DOI] [PubMed] [Google Scholar]
  42. Schwartz L. M., McCleskey E. W., Almers W. Dihydropyridine receptors in muscle are voltage-dependent but most are not functional calcium channels. 1985 Apr 25-May 1Nature. 314(6013):747–751. doi: 10.1038/314747a0. [DOI] [PubMed] [Google Scholar]
  43. Scott R. H., Dolphin A. C. Activation of a G protein promotes agonist responses to calcium channel ligands. Nature. 1987 Dec 24;330(6150):760–762. doi: 10.1038/330760a0. [DOI] [PubMed] [Google Scholar]
  44. Sharp A. H., Imagawa T., Leung A. T., Campbell K. P. Identification and characterization of the dihydropyridine-binding subunit of the skeletal muscle dihydropyridine receptor. J Biol Chem. 1987 Sep 5;262(25):12309–12315. [PubMed] [Google Scholar]
  45. Sieber M., Nastainczyk W., Zubor V., Wernet W., Hofmann F. The 165-kDa peptide of the purified skeletal muscle dihydropyridine receptor contains the known regulatory sites of the calcium channel. Eur J Biochem. 1987 Aug 17;167(1):117–122. doi: 10.1111/j.1432-1033.1987.tb13311.x. [DOI] [PubMed] [Google Scholar]
  46. Simon S. A., McIntosh T. J., Latorre R. Influence of cholesterol on water penetration into bilayers. Science. 1982 Apr 2;216(4541):65–67. doi: 10.1126/science.7063872. [DOI] [PubMed] [Google Scholar]
  47. Smith J. S., McKenna E. J., Ma J. J., Vilven J., Vaghy P. L., Schwartz A., Coronado R. Calcium channel activity in a purified dihydropyridine-receptor preparation of skeletal muscle. Biochemistry. 1987 Nov 3;26(22):7182–7188. doi: 10.1021/bi00396a046. [DOI] [PubMed] [Google Scholar]
  48. Striessnig J., Moosburger K., Goll A., Ferry D. R., Glossmann H. Stereoselective photoaffinity labelling of the purified 1,4-dihydropyridine receptor of the voltage-dependent calcium channel. Eur J Biochem. 1986 Dec 15;161(3):603–609. doi: 10.1111/j.1432-1033.1986.tb10484.x. [DOI] [PubMed] [Google Scholar]
  49. Takahashi M., Seagar M. J., Jones J. F., Reber B. F., Catterall W. A. Subunit structure of dihydropyridine-sensitive calcium channels from skeletal muscle. Proc Natl Acad Sci U S A. 1987 Aug;84(15):5478–5482. doi: 10.1073/pnas.84.15.5478. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Tanabe T., Takeshima H., Mikami A., Flockerzi V., Takahashi H., Kangawa K., Kojima M., Matsuo H., Hirose T., Numa S. Primary structure of the receptor for calcium channel blockers from skeletal muscle. Nature. 1987 Jul 23;328(6128):313–318. doi: 10.1038/328313a0. [DOI] [PubMed] [Google Scholar]
  51. Tsien R. W., Lipscombe D., Madison D. V., Bley K. R., Fox A. P. Multiple types of neuronal calcium channels and their selective modulation. Trends Neurosci. 1988 Oct;11(10):431–438. doi: 10.1016/0166-2236(88)90194-4. [DOI] [PubMed] [Google Scholar]
  52. Uehara A., Hume J. R. Interactions of organic calcium channel antagonists with calcium channels in single frog atrial cells. J Gen Physiol. 1985 May;85(5):621–647. doi: 10.1085/jgp.85.5.621. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Valdivia H. H., Coronado R. Inhibition of dihydropyridine-sensitive calcium channels by the plant alkaloid ryanodine. FEBS Lett. 1989 Feb 27;244(2):333–337. doi: 10.1016/0014-5793(89)80557-5. [DOI] [PubMed] [Google Scholar]
  54. Vilven J., Coronado R. Opening of dihydropyridine calcium channels in skeletal muscle membranes by inositol trisphosphate. Nature. 1988 Dec 8;336(6199):587–589. doi: 10.1038/336587a0. [DOI] [PubMed] [Google Scholar]
  55. Williams J. S., Grupp I. L., Grupp G., Vaghy P. L., Dumont L., Schwartz A., Yatani A., Hamilton S., Brown A. M. Profile of the oppositely acting enantiomers of the dihydropyridine 202-791 in cardiac preparations: receptor binding, electrophysiological, and pharmacological studies. Biochem Biophys Res Commun. 1985 Aug 30;131(1):13–21. doi: 10.1016/0006-291x(85)91763-2. [DOI] [PubMed] [Google Scholar]
  56. Yatani A., Imoto Y., Codina J., Hamilton S. L., Brown A. M., Birnbaumer L. The stimulatory G protein of adenylyl cyclase, Gs, also stimulates dihydropyridine-sensitive Ca2+ channels. Evidence for direct regulation independent of phosphorylation by cAMP-dependent protein kinase or stimulation by a dihydropyridine agonist. J Biol Chem. 1988 Jul 15;263(20):9887–9895. [PubMed] [Google Scholar]

Articles from The Journal of General Physiology are provided here courtesy of The Rockefeller University Press

RESOURCES